EverHint – Momentum Swing — Breakout Standard for Mar 18, 2026 – 7 Signals – Healthcare Leads (3)

7 signals. Healthcare leads (3). 4 with insider selling. 1 with congressional selling. price range $43-$462. sectors: Healthcare (3), Technology (2), Consumer Cyclical (1). 2 report earnings within 7 days. full analyst coverage, 57.1% have news.

What This Signal Is (Quick)

Breakout Standard is a momentum swing trading strategy focused on Stocks within 3% of 52-week high - standard breakout momentum setups.

Signal Type: Breakout (momentum continuation)

What Makes This Signal:

  • Stock showing strong momentum near or at highs
  • Increased volume confirms institutional interest
  • Breaking out or consolidating near resistance
  • Stocks within 3% of 52-week high - standard breakout momentum setups

Ideal For: Swing traders looking for breakout opportunities with confirmed momentum

Key Criteria:

  • Strong RSI momentum (configurable thresholds)

  • Volume surge above average

  • Price momentum confirmation

  • Minimum ADV: $25M+ (varies by variant)

  • Earnings buffer: 7 days pre/post earnings

  • Variant-specific filters applied

Holding Period: 1-4 weeks
Risk Level: Medium-High


How We Ranked Today

Ranked by composite momentum score (higher = stronger momentum)


📊 Momentum Swing — Breakout Standard Signals (7 Total)

Ranked by score:

Rank Ticker Company Sector Last ($) Score Vol Thrust @52w Insider Net Days → Earnings Est EPS Mkt Cap ($B)
1 TERN Terns Pharmaceuticals,... Healthcare 47.78 1.000 1.62x 0.0% $-3.0M 1 $-1.63 4.3
2 DOCN DigitalOcean Holdings,... Technology 82.48 0.783 1.88x 0.0% 47 $2.79 7.6
3 PTGX Protagonist Therapeuti... Healthcare 97.09 0.717 2.63x 0.0% $-10.9M 47 $4.50 6.2
4 QSR Restaurant Brands Inte... Consumer Cyclical 74.26 0.333 3.17x 0.0% 49 $6.09 24.4
5 CRC California Resources C... Energy 64.20 0.283 1.83x 0.0% $5.24 5.7
6 MU Micron Technology, Inc. Technology 461.73 0.217 1.64x 0.0% $-740K 0 $0.00 519.7
7 BTSG BrightSpring Health Se... Healthcare 43.07 0.000 1.61x 0.0% $-11.7M $5.16 8.3

Field Notes

Sector concentration: Healthcare (3), Technology (2), Consumer Cyclical (1)

Insider selling: BTSG (BrightSpring Health Services, Inc. Common Stock, $-11.7M), MU (Micron Technology, Inc., $-740K), PTGX (Protagonist Therapeutics, Inc., $-10.9M)

Near-term earnings: MU (Micron Technology, Inc.), TERN (Terns Pharmaceuticals, Inc.) report within 7 days. Higher volatility risk.

Data coverage: 57.1% insider, 14.3% congressional (1 older/1y), 71.4% earnings, 100.0% analyst, 57.1% news


Peer Analysis

Understanding how these stocks relate to their industry peers:

MU (Micron Technology, Inc.): Leads 10 peers: LRCX ($224.71, -0.8%), AMAT ($349.47, -0.8%), CRM ($194.34, -0.5%), QCOM ($130.43, -0.9%), IBM ($251.60, -1.8%) | Peer of: AMAT ($349.47, -0.8%), AMD ($199.46, +1.6%), ASML ($1355.17, -2.5%) and 8 more

DOCN (DigitalOcean Holdings, Inc.): Leads 10 peers: DLO ($11.45, -2.4%), SPSC ($60.05, -0.6%), VRNS ($24.48, +0.8%), CLBT ($14.58, -0.8%), QLYS ($96.64, +1.6%) | Peer of: AVT ($59.79, -0.4%), BOX ($24.64, +0.7%), CLBT ($14.58, -0.8%) and 10 more

PTGX (Protagonist Therapeutics, Inc.): Leads 9 peers: ACLX ($114.51, -0.0%), ALKS ($27.20, -1.6%), TGTX ($30.04, -4.7%), KYMR ($79.14, -2.5%), IMVT ($23.60, -6.0%) | Peer of: ACLX ($114.51, -0.0%), ALKS ($27.20, -1.6%), KRYS ($250.83, -2.1%) and 4 more

CRC (California Resources Corporation): Leads 10 peers: MUR ($38.17, +3.8%), MGY ($30.16, +0.7%), MTDR ($57.58, -0.1%), VAL ($92.54, -4.9%), PBF ($47.09, +5.7%) | Peer of: CRK ($20.63, +0.1%), CVI ($32.91, +10.4%), ENPH ($43.28, -3.2%) and 11 more

QSR (Restaurant Brands International Inc.): Leads 10 peers: DRI ($200.71, -1.6%), YUMC ($52.76, -2.3%), LI ($17.05, -5.1%), DPZ ($376.92, -4.9%), ULTA ($520.65, -0.5%) | Peer of: CMG ($32.64, -5.2%), DRI ($200.71, -1.6%), EXPE ($240.04, -0.5%) and 10 more

TERN (Terns Pharmaceuticals, Inc.): Leads 9 peers: ORIC ($10.86, -10.0%), PGEN ($3.27, -7.6%), IMTX ($9.68, -1.5%), ELVN ($27.25, -1.9%), AMLX ($13.79, -3.5%) | Peer of: IMTX ($9.68, -1.5%), NVAX ($10.01, -5.9%), ORIC ($10.86, -10.0%) and 5 more

BTSG (BrightSpring Health Services, Inc. Common Stock): Leads 10 peers: BRKR ($34.03, +0.9%), CHE ($383.21, -4.0%), IRTC ($117.33, -0.2%), KRYS ($250.83, -2.1%), HQY ($79.57, +0.2%) | Peer of: BRKR ($34.03, +0.9%), CHE ($383.21, -4.0%), HQY ($79.57, +0.2%) and 3 more


Congressional Activity

MU (Micron Technology, Inc.) 🔴 Bearish (1y)

  • 1 sale by 1 member
  • Top seller: Sen. John Boozman (AR) - 1 transaction ($1,001 - $15,000)

Recent Headlines

BTSG (BrightSpring Health Services, Inc. Common Stock)

  • BrightSpring Health Services, Inc. (BTSG) Analyst/Investor Day Transcript (source)
  • BrightSpring Health Services, Inc. (BTSG) Moves 7.8% Higher: Will This Strength Last? (source)
  • 5 Stocks With Recent Price Strength Despite Geopolitical Conflicts (source)
  • 3 Medical Service Industry Stocks Set to Counter Workforce Issues (source)
  • 1,733,548 Shares in BrightSpring Health Services, Inc. $BTSG Acquired by 8 Knots Management LLC (source)
  • Wall Street Analysts See a 32.74% Upside in BrightSpring Health Services, Inc. (BTSG): Can the Stock Really Move This High? (source)
  • Bet on These 4 High-Flying Stocks With Increasing Cash Flows (source)

PTGX (Protagonist Therapeutics, Inc.)

  • Protagonist Therapeutics, Inc. (PTGX) Discusses FDA Approval of ICOTYDE for Moderate to Severe Plaque Psoriasis Treatment Transcript (source)
  • Protagonist Therapeutics Announces U.S. FDA Approval of ICOTYDE(TM) (icotrokinra) for the Treatment of Moderate to Severe Plaque Psoriasis (source)
  • Protagonist Therapeutics, Inc. (PTGX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript (source)

QSR (Restaurant Brands International Inc.)

  • Why DRI And QSR Are Outpacing McDonald's Stock (source)
  • Restaurant Brands International (TSE:QSR) Shares Pass Above Fifty Day Moving Average – What’s Next? (source)

TERN (Terns Pharmaceuticals, Inc.)

  • This Biotech Fund Sold $8 Million of Terns Stock Last Quarter, but Here's Why It Still Seems Very Bullish (source)
  • This Biotech Attracted a $181 Million Investment During a Staggering 1,300% Stock Rally (source)
  • Terns Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:TERN) (source)
  • 4 Biotech Stocks to Watch for Potential Upside in 2026 (source)

Market Context

The broad market indices declined today, with the S&P 500 down 1.09%, Nasdaq falling 1.21%, and Dow Jones dropping 1.43%, signaling a short-term bearish trend and waning risk appetite among investors. For a momentum swing breakout strategy, this environment challenges upside breakouts, as downward momentum can accelerate selling pressure and false breakouts. However, the elevated VIX at 24.59, up 14.32%, introduces heightened volatility that amplifies intraday swings, potentially creating opportunities for quick reversals or breakout confirmations if volume supports moves beyond key levels.

High volatility from the surging VIX enhances the potential for larger price swings, which aligns well with momentum swing breakouts by providing the range needed for entries, but it also raises the risk of whipsaws in a risk-off climate. Reduced risk appetite, evident in the uniform index declines, may temper aggressive positioning, favoring shorter holding periods and tighter stops to manage downside exposure.

Sector rotation appears defensive, with Healthcare generating the top signals among the seven total, suggesting capital flows into resilient areas amid broader weakness. This dynamic supports momentum strategies targeting relative strength in Healthcare breakouts, though traders should monitor for sustained volatility that could either validate moves or exacerbate reversals in a downtrending market.

Vlad's Take (EverHint)

Today's signals: Strong sector concentration in Healthcare (3 signals) suggests sector-specific rotation. 4 signals showing insider selling warrant caution.


Sharing Call-to-Action

✅ If this added value to your research, consider liking, sharing, or subscribing. It genuinely helps.


Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

This is not financial advice. Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/